The pathology of soft tissue sarcomas

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Soft tissue sarcomas are rare, heterogeneous malignancies with mesenchymal differentiation, affecting approximately 5/100,000 individuals annually.
• Diagnostic accuracy is challenged by rarity and morphologic heterogeneity, necessitating specialized expertise and large case access.
• Current classification relies on the 2013 WHO system, integrating morphology, immunohistochemistry, and molecular genetics.

Purpose of the Study:

• To highlight the integrated diagnostic approach for soft tissue sarcomas.
• To emphasize the roles of morphology, immunohistochemistry, and molecular genetics in sarcoma classification.
• To discuss the limitations of current grading systems and the move towards prognostic nomograms.

Main Methods:

• Morphologic evaluation focusing on cell shape, growth patterns, background quality, and vascular architecture.
• Immunohistochemical characterization using differentiation markers, interpreted alongside morphology.
• Molecular genetic analysis for subtyping, supporting non-canonical presentations, and differentiating from benign mimics.

Main Results:

• Morphology, immunohistochemistry, and molecular genetics are crucial for accurate soft tissue sarcoma diagnosis.
• Immunohistochemistry offers sensitivity but limited specificity, requiring contextual interpretation.
• Molecular genetics aids in distinguishing subtypes and ruling out benign conditions.

Conclusions:

• Accurate soft tissue sarcoma diagnosis is a multimodal process.
• Histologic typing alone is insufficient for predicting clinical outcomes.
• Prognostic nomograms incorporating histotype are emerging to improve malignancy estimation.